Momenta Pharmaceuticals (MNTA) PT Raised to $40 at Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore raised the price target on Momenta Pharmaceuticals (NASDAQ: MNTA) to $40.00 (from $23.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
